CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Intradiscal PRP & BMC Injectionsprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04102761
NCT04102761N/ACompleted
CompareCT.gov

Platelet Rich Plasma and Bone Marrow Aspirate for Lumbar Intradiscal Injections: A Multicenter Prospective Randomized Controlled Trial in Patients With Internal Disc Disruption

Annu Navani·interventional·Posted Sep 25, 2019·Updated Aug 9, 2021

In Brief

A clinical study evaluating Intradiscal PRP & BMC Injections for Internal Disc Disruption. Completed, enrolled 45 participants across 4 sites.

Detailed Summary

The condition being studied is chronic low back or leg pain in patients with internal disc disruption (IDD). The intervention to be studied is the intradiscal delivery of autologous Platelet Rich Plasma (PRP) or bone marrow concentrate (BMC) into the nucleus pulposus of the disrupted disc(s).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInternal Disc Disruption
CountriesUnited States
CollaboratorsAndrews Research & Education Foundation

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 25, 2019
Enrollment StartMar 27, 2018
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 6.8 years ago

Interventions

Intradiscal PRP & BMC Injectionsprocedure

The intervention to be studied is the intradiscal delivery of autologous Platelet Rich Plasma (PRP) or bone marrow concentrate (BMC) into the nucleus pulposus of the disrupted disc(s).